Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2016, Article ID 5794910, 7 pages
http://dx.doi.org/10.1155/2016/5794910
Research Article

Lack of Association between Pulse Steroid Therapy and Bone Mineral Density in Patients with Multiple Sclerosis

Karadeniz Technical University, 61080 Trabzon, Turkey

Received 30 September 2015; Revised 7 December 2015; Accepted 13 December 2015

Academic Editor: Bianca Weinstock-Guttman

Copyright © 2016 Serap Zengin Karahan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Compston and A. Coles, “Multiple sclerosis,” The Lancet, vol. 372, no. 9648, pp. 1502–1517, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Dionyssiotis, “Bone loss and fractures in multiple sclerosis: focus on epidemiologic and physiopathological features,” International Journal of General Medicine, vol. 4, pp. 505–509, 2011. View at Publisher · View at Google Scholar
  3. R. Dobson, S. Ramagopalan, and G. Giovannoni, “Bone health and multiple sclerosis,” Multiple Sclerosis, vol. 18, no. 11, pp. 1522–1528, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. J. C. Gibson and G. D. Summers, “Bone health in multiple sclerosis,” Osteoporosis International, vol. 22, no. 12, pp. 2935–2949, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. P. Hearn and E. Silber, “Osteoporosis in multiple sclerosis,” Multiple Sclerosis, vol. 16, no. 9, pp. 1031–1043, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Sioka, S. Papakonstantinou, A. Fotopoulos et al., “Bone mineral density in ambulatory patients with multiple sclerosis,” Neurological Sciences, vol. 32, no. 5, pp. 819–824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Terzi, M. Terzi, B. Tander, F. Cantürk, and M. Onar, “Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables,” Journal of Clinical Neuroscience, vol. 17, no. 10, pp. 1260–1264, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Triantafyllou, I. Lambrinoudaki, P. Thoda et al., “Lack of association between vitamin D levels and bone mineral density in patients with multiple sclerosis,” Journal of the Neurological Sciences, vol. 313, no. 1-2, pp. 137–141, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. Ş. Tüzün, A. Altintaş, I. Karacan, S. Tangürek, S. Saip, and A. Siva, “Bone status in multiple sclerosis: beyond corticosteroid,” Multiple Sclerosis, vol. 9, no. 6, pp. 600–604, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Weinstock-Guttman, E. Gallagher, M. Baier et al., “Risk of bone loss in men with multiple sclerosis,” Multiple Sclerosis, vol. 10, no. 2, pp. 170–175, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. T. Kampman, E. F. Eriksen, and T. Holmøy, “Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications?” Acta Neurologica Scandinavica, vol. 124, no. 191, pp. 44–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S. L. Silverman and N. E. Lane, “Glucocorticoid-induced osteoporosis,” Current Osteoporosis Reports, vol. 7, no. 1, pp. 23–26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. R. S. Weinstein, “Glucocorticoid-induced osteoporosis and osteonecrosis,” Endocrinology and Metabolism Clinics of North America, vol. 41, no. 3, pp. 595–611, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. C. H. Polman, S. C. Reingold, B. Banwell et al., “Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria,” Annals of Neurology, vol. 69, no. 2, pp. 292–302, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. F. Kurtzke, “Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS),” Neurology, vol. 33, no. 11, pp. 1444–1452, 1983. View at Publisher · View at Google Scholar · View at Scopus
  16. J. A. Kanis, L. J. Melton III, C. Christiansen, C. C. Johnston, and N. Khaltaev, “The diagnosis of osteoporosis,” Journal of Bone and Mineral Research, vol. 9, no. 8, pp. 1137–1141, 1994. View at Google Scholar · View at Scopus
  17. A. Ayatollahi, M. R. Mohajeri-Tehrani, and S. Nafissi, “Factors affecting bone mineral density in multiple sclerosis patients,” Iranian Journal of Neurology, vol. 12, pp. 19–22, 2013. View at Google Scholar
  18. V. Zikán, M. Tyblova, I. Raška, M. Luchavova, D. Michalska, and E. Havrdova, “Bone mineral density and body composition in men with multiple sclerosis,” Bone, vol. 50, supplement 1, p. S145, 2012. View at Publisher · View at Google Scholar
  19. F. Cosman, J. Nieves, L. Komar et al., “Fracture history and bone loss in patients with MS,” Neurology, vol. 51, no. 4, pp. 1161–1165, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. T. P. van Staa, H. G. M. Leufkens, and C. Cooper, “The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis,” Osteoporosis International, vol. 13, no. 10, pp. 777–787, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. T. P. Van Staa, H. G. M. Leufkens, L. Abenhaim, B. Zhang, and C. Cooper, “Oral corticosteroids and fracture risk: relationship to daily and cumulative doses,” Rheumatology, vol. 39, no. 12, pp. 1383–1389, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Vestergaard, L. Rejnmark, and L. Mosekilde, “Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures,” Calcified Tissue International, vol. 82, no. 4, pp. 249–257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. M. Moen, E. G. Celius, L. Sandvik, L. Nordsletten, E. F. Eriksen, and T. Holmoøy, “Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome,” Neurology, vol. 77, no. 2, pp. 151–157, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. S. R. Schwid, A. D. Goodman, J. E. Puzas, M. P. McDermott, and D. H. Mattson, “Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis,” Archives of Neurology, vol. 53, no. 8, pp. 753–757, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. L. H. Steffensen, S. I. Mellgren, and M. T. Kampman, “Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis,” Journal of Neurology, vol. 257, no. 3, pp. 410–418, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Zorzon, R. Zivadinov, L. Locatelli et al., “Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis,” European Journal of Neurology, vol. 12, no. 7, pp. 550–556, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Ozgocmen, S. Bulut, N. Ilhan, A. Gulkesen, O. Ardicoglu, and Y. Özkan, “Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity,” Journal of Bone and Mineral Metabolism, vol. 23, no. 4, pp. 309–313, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Tyblova, T. Kalincik, V. Zikan, and E. Havrdova, “Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis,” European Journal of Neurology, vol. 22, no. 4, pp. 624–632, 2015. View at Publisher · View at Google Scholar
  29. M. C. Mojtahedi, E. M. Snook, R. W. Motl, and E. M. Evans, “Bone health in ambulatory individuals with multiple sclerosis: impact of physical activity, glucocorticoid use, and body composition,” Journal of Rehabilitation Research and Development, vol. 45, no. 6, pp. 851–862, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Stenager and K. Jensen, “Fractures in multiple sclerosis,” Acta Neurologica Belgica, vol. 91, no. 5, pp. 296–302, 1991. View at Google Scholar · View at Scopus
  31. M. R. Law and A. K. Hackshaw, “A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect,” British Medical Journal, vol. 315, no. 7112, pp. 841–846, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Kirbas, S. Kirbas, O. Anlar, A. K. Turkyilmaz, M. C. Cure, and H. Efe, “Investigation of the relationship between vitamin D and bone mineral density in newly diagnosed multiple sclerosis,” Acta Neurologica Belgica, vol. 113, no. 1, pp. 43–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Nieves, F. Cosman, J. Herbert, V. Shen, and R. Lindsay, “High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis,” Neurology, vol. 44, no. 9, pp. 1687–1692, 1994. View at Publisher · View at Google Scholar · View at Scopus